GTS Securities’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.16K Buy
+65,000
New +$5.06K ﹤0.01% 1674

Other funds holding DMIIR

GTS Securities's DMIIR Position: Q3 2026 in Review

GTS Securities opened a new position in Drugs Made In America Acquisition II Corp Right (DMIIR) in Q3 2026: 65,000 shares worth $4.16K. The stake represents ﹤0.01% of the portfolio and ranks #1674 among its holdings.

64 funds tracked by Wall St. Rank hold DMIIR as of Q3 2026.

  • GTS Securities held 65,000 shares of Drugs Made In America Acquisition II Corp Right worth $4.16K as of Q3 2026.
  • Drugs Made In America Acquisition II Corp Right was a new GTS Securities position in Q3 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1674 holding.
  • 64 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.